CKD

SGLT2 inhibitor — eligibility & safety

Indications across DKD, non-DKD, HFpEF/HFrEF, and contraindications.

drug safetySGLT2i

Required inputs

eGFR (mL/min/1.73 m²)
UACR (mg/g)
Type 2 diabetes
Heart failure
Type 1 diabetes
Pregnancy/lactation
Recurrent DKA history

Equation or source

KDIGO 2024 CKD; ESC 2023 HF update; dapa/empa/cana labels.

Open interactive calculator